Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 20, 2010

Premium

Illumina has named Melina Cimler to be vice president of quality and regulatory affairs. She will lead the company's quality and regulatory organizations to support its development, manufacturing, and distribution activities. Cimler formerly worked in similar positions at Beckman Coulter, Abbott Molecular, and Gen-Probe. Prior to joining Illumina, Cimler was president of PandiaDx Consulting. She holds a PhD in pharmacology from the University of Washington.

As an incentive to join the company, Illumina has granted Cimler an option to purchase 120,000 shares of its common stock. The option's terms are an exercise price equal to the closing fair market value of Illumina's common stock on the grant date of July 12, 2010; a 10-year term, and vesting over four years with 25 percent of the option vesting one year from the grant date and 1/48th of the option vesting monthly thereafter.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.